Showing 1216 Results
The CER Conversation Continues at the Fifth Comparative Effectiveness Summit
During the summer months, comparative effectiveness research (CER) sparked a number of conversations among health care stakeholders. There were discussions about a New England Journal of Medicine…
One Year Later: The FDA Safety and Innovation Act
We're pleased to share with you a guest post from Cynthia Bens, vice president, public policy, Alliance for Aging Research. It’s been a little over a year since President Obama signed the Food and…
Getting to Know NPC’s Chief Science Officer
This month’s Journal of Comparative Effectiveness Research includes a special interview with NPC’s chief science officer, Dr. Robert Dubois. In the interview with JCER, Dr. Dubois talks about how he…
Rapid Learning Health Systems: Speed Is Good, With Caution
NPC’s Chief Science Officer, Dr. Robert Dubois, and Merck & Co.’s Executive Director, Dr. Newell McElwee, recently authored a column in the Journal of Comparative Effectiveness Research. The…
NPC Seeking Research Proposals on Individual Treatment Effects
The Patient-Centered Outcomes Research Institute isn’t the only organization seeking research proposals—the National Pharmaceutical Council (NPC) is, too!
September 10 NPC Webinar: Can We Bring Clarity, Consistency and Transparency to Payer Coverage Decisions?
What goes into the coverage, or formulary, decisions that health insurers make? A lack of transparency in the process can make it hard to tell. As a result, coverage decisions (and, ultimately,…
Catch NPC Researchers Out and About: The When and Where
The researchers here at NPC have a busy, information-packed month ahead of them. They'll be speaking at various conferences about the use of real-world evidence, pharmaceuticals and bundled payments,…
NPC Webinar: Can We Bring Clarity, Consistency and Transparency to Payer Coverage Decisions?
Why are some treatments covered under a health care plan, while other treatments are not? How do payers evaluate the information needed to make coverage decisions?There is a bit of a "black box"…
Putting Patients First®: Paving a Path to Useful CER
How do patients, providers, and payers know whether health information is credible, accurate, useful or appropriate?Comparative effectiveness research (CER) has the potential to improve health…
NPC Comments on Appointment of AHRQ Director
National Pharmaceutical Council (NPC) President Dan Leonard today released the following statement about the appointment of Richard Kronick, PhD, as the new director of the Agency for Healthcare…
A Step Toward Clear, Consistent, Transparent Formulary Decisions
The process that health insurers use to determine health coverage is not always clear, making it hard for patients, providers and biopharmaceutical manufacturers to predict whether a particular…
Communicating Research Findings: Changes to FDAMA 114?
With his commentary in the New England Journal of Medicine, Tufts Medical Center Economist Dr. Peter Neumann re-sparked the debate about the type of information that pharmaceutical companies are…